Overview

A Study of Flovent in Patients With Eosinophilic Esophagitis

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effects (both good and bad) of high dose swallowed fluticasone propionate (Flovent) in subjects with eosinophilic esophagitis (EoE).
Phase:
Phase 2
Details
Lead Sponsor:
Marc Rothenberg
Marc Rothenberg, MD
Treatments:
Fluticasone
Xhance